Epocrates Inc., a vendor of point of care drug reference content available via mobile computing devices, expects in coming days to conduct an initial public offering of stock valued at up to $92.5 million.
The San Mateo, Calif.-based firm previously anticipated proceeds of up to about $55 million and recently raised the IPO's value. The company now expects to sell up to 6.164 million shares between $13 and $15 per share.
Epocrates had 2008 net income of $7.4 million on $83.3 million in revenue, 2009 net income of $7.7 million on $93.7 million in revenue; and net income of $1.1 million on $73.7 million in revenue during the first nine months of 2010.
More information is available at epocrates.com.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access